Ginseng (the root of Panax ginseng C. A. Meyer), which contains protopanaxadiols and protopanaxatriols as its main constituents, has been used for many disorders, such as cancer, diabetes, inflammation, and hyperlipidemia. Of these ginsenosides, protopanaxadiol ginsenoside Rh2 alone is reported to inhibit adipogenesis in 3T3-L1 in vitro. Therefore, we investigated the effect of protopanaxatriol ginsenoside Rh1 on adipogenesis in 3T3 Key words Panax ginseng; ginsenoside Rh1; adipogenesis; obesity Obesity is a chronic, stigmatized, and highly-priced disease that is intractable and its prevalence is increasing throughout most of the world.
Obesity is a chronic, stigmatized, and highly-priced disease that is intractable and its prevalence is increasing throughout most of the world. 1, 2) It is an abnormal condition accumulating lipid in adipose tissues, which secrete adipokines (tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, leptin, resistin and adiponectin) closely associated with inflammation. Obesity is caused by various environmental and genetic factors. Of them, a main environmental factor is the consumption of a high-fat diet. The obesity is an important risk factor for various diseases such as cardiovascular diseases, type 2 diabetes and some cancers caused by hyperglycemia, insulin resistance, dyslipidemia and hypertension. Therefore, it is very important to prevent obesity for a healthy life.
Ginseng (the root of Panax ginseng C. A. Meyer), which contains ginsenosides classified into protopanaxtriols and protopanaxdiols as main constituents, has been used in Chinese traditional medicines for type 2 diabetes, inflammation, cancer and hyperlipidemia. 3, 4) Of ginsenosides, protopanaxadiols such as ginsenoside Rb1, ginsenoside Rh2 and compound K, have anti-cancer effect, enhancement of proliferation and differentiation of bone marrow cells. 5, 6) Ginsenoside Rh2 also exhibits the inhibitory effect against 3T3-L1 cells differentiation in in vitro study. 7, 8) However, in vivo study of ginsenoside Rh2 has not been performed. Among protopanaxatriols, ginsenosides Re and Rg1 are main constituents in ginseng, followed by ginsenoside Rh1. However, ginsenosides Re and Rg1 are metabolized to ginsenoside Rh1 or protopanaxatriol by human intestinal microfora.
9) The ginsenoside Rh1 exhibits anti-allergic and anti-inflammatory and estrogenic effects. 10, 11) However, its anti-obesity effect has not been studied.
As a part of our studies on anti-obesity constituents from natural medicines, we isolated the main constituents, protopanxatriol ginsenosides Re, Rg1 and Rh1, from ginseng in our preliminary experiment. Therefore, we examined the effect of ginsenoside Rh1 on the adipogenesis in 3T3-L1 cells and dietinduced obesity (DIO) mice.
MATeRIALS AND MeTHODS
Materials Insulin, isobutylmethylxanthine, dexamethasone, Oil red O reagent, Dulbecco's modified Eagle's medium (DMeM), fetal bovine serum (FBS) and antibiotics (AB), were all purchased from Sigma Chemical Co. (MO, U.S.A.). Antiperoxisome proliferator-activated receptor (PPAR)γ antibody and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody were purchased from Santa Cruz Biotechnology (CA, U.S.A.). Ginsenoside Rh1 was isolated from the root of Panax ginseng according to a previously published method. 9, 10) Cell Culture Mouse embryo fibroblasts 3T3-L1 cells were obtained from American Type Culture Collection (VA, U.S.A.) and incubated in DMeM, containing 10% FBS and 1% AB, at 37°C and 5.6% CO 2 atmosphere. To induce differentiation, two days after confluence, preadipocytes (designated day 0) were cultured in the differentiation medium (DM), which is consisted of DMeM, 10% FBS, 1% AB, and DMI (0.28 unit/mL insulin, 0.5 mM isobutylmethylxanthine and 1 µM dexamethasone) for 2 d in the presence or absence of 50 µM and 100 µM of ginsenoside Rh1, and switched to DM containing 10% FBS and 10 µg/mL insulin and then changed to DMeM medium with 10% FBS for every 2 d.
Oil-Red O Staining Oil red O staining was performed on day 8. Briefly, cells were washed twice, with phosphate-buffered saline (PBS), and were fixed with 4% paraformaldehyde for 1 h. They were washed three times with water and stained with Oil red O (6 parts of 0.6% Oil red O dye in isopropanol and 4 parts of water) for 1 h. Excess stain was removed by washing with water and the stained cells were dried. Spectrophotometric quantification of the stain was performed by dissolving the stained oil droplets in 100% isopropanol for 10 min. Optical density was then measured at 500 nm.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Total RNA was extracted from the 3T3-L1 cells and epididymal fat, using a total RNA extraction kit (Qiagen, Germany). cDNA synthesis for PPAR-γ, CCAAT/enhancer-binding protein (C/eBP)-α, fatty acid synthase (FAS), CD68, F4/80, TNF-α, IL-1β, and IL-6 was performed with 2 µg of total RNA, oligodT primers, and a reverse transcriptase in total volume of 40 µL. PCR reactions were performed in a total volume of 50 µL, comprising 4 µL of cDNA product, and 25 µL of Premix EX Taq (Takara Bio Inc.). PPAR-γ for, 5′-ACT GCC TAT GAG CTC TTC AC-3′, and rev, 5′-CAA TCG GAT GGT TCT TCG GA-3′; C/EBP-α for, 5′-TGG ACA AGA ACA GCA ACG AG-3′, rev 5′-AAT CTC CTA GTC CTG GCT TG-3′; FAS for, 5′-TGC TCC CAG CTG CAG GC-3′, rev, 5′-GCC CGG TAG CTC TGG GTG TA-3′; adipose fatty acid binding protein (aFABP) for, 5′-ATG AGT ACT ACA TGG CTA-3′, rev, 5′-CAA TGG GGG CCA GAT CAT-3′; GAPDH for, 5′-CAT CAC CAT CTT CCA GGA GCG-3′, rev, 5′-TGA CCT TGC CCA CAG CCT TG-3′; CD68 for, 5′-TTC TGC TGT GGA AAT GCA AG-3′, rev, 5′-AGA GGG GCT GGT AGG TTG AT-3′; F4/80 for, 5′-AGA TGG GGG ATG ACC ACA CTT-3′, rev, 5′-TGT TCA GGG CAA ACG TCT CG-3′; TNF-α for, 5′-TCC CCA AAG GGA TGA GAA GTT C-3′, rev, 5′-TCA TAC CAG GGT TTG AGC TCA G-3′; IL-6 for, 5′-TGA CAA AAG AGT TGT GCA ATG GC-3′, rev, 5′-GAA TGT CCA CAA ACT GAT ATG CTT-3′. The reaction conditions were as follows: denaturation at 94°C for 30 s; annealing at 50°C (aFABP), 56°C (PPAR-γ, FAS, GAPDH, IL-6, CD68), 58°C (TNF-α, F4/80), 60°C (eBP-α) for 30 s; and extension at 72°C for 1 min. Varying cycles of PCR were carried out to determine the linear ranges of PCR products. PCR products were electrophoresed on a 2% agarose gel and visualized with UV.
Immunoblotting epididymal fat pad of mice was homogenized in radio immunoprecipitation assay (RIPA) lysis buffer (Pierce, IL, U.S.A.). Total proteins (20 µg) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to polyvinylidenedifluoride membranes, and then hybridized overnight, at 4°C with 1 : 1000 diluted PPAR-γ, C/eBP-α, FAS, aFABP antibodies. After incubation with 1 : 2000 diluted anti-rabbit or anti-mouse immunoglobulin G secondary antibody for 1 h at room temperature, it was then washed 3 times with PBST (PBS+ Tween 20 0.1%) for 10 min. Bands were visualized with enhanced chemiluminescence reagent.
Enzyme-Linked Immunosorbent Assay (ELISA) For the eLISA of IL-1β, IL-6 and TNF-α, the epididymal fats were homogenized in a 600 µL of ice-cold RIPA lysis buffer, which contained 0.1% protease inhibitor cocktail, and 1% phosphatase inhibitor cocktail. The lysate was centrifuged (10000×g, 4°C) for 15 min, and the supernatant was transferred to 96-well eLISA plates. IL-1β, TNF-α and IL-6 concentrations were determined, using commercial eLISA kits (Pierce, IL, U.S.A.).
Animals Male C57BL/6J mice were purchased from Central Lab. Animal Inc. (Seoul, Korea) at the age of 4 weeks. After 3 d of acclimation, mice were either placed in a low-fat diet (LFD, 10% of calories from fat; Research, NJ, U.S.A.) or a high-fat diet (HFD, 60% of calories from; Research, NJ, U.S.A.). All mice were maintained under standardized conditions with the cycle of 12 h light, and 12 h dark.
Mice were separated into 3 groups, LFD, HFD and HFDRh1. each group is consisted of ten mice. LFD group fed LFD for 8 weeks. HFD group fed HFD for 8 weeks. HFDRh1 group fed HFD diet for 4 weeks and then simultaneously treated with HFD and 20 mg/kg/d ginsenoside Rh1, which was orally administrated. Weight and food intake of mice were measured daily. After finishing treatment for 4 weeks, blood and epididymal fats were collected for further analysis.
For histological analysis, the epididymal fat pad was removed and fixed in 4% paraformaldehyde. The fat pads were subsequently dehydrated by the exposure to increasing ethanol concentrations, and embedded in paraffin, sectioned with 7 µm thickness, and stained with hematoxylin-eosin for microscopic assessment.
All experiments were performed in accordance with the NIH and Kyung Hee University guidelines for Laboratory Animals Care and Use. The study was approved by the committee for the Care and Use of Laboratory Animals in the College of Pharmacy, Kyung Hee University.
Real Time-Polymerase Chain Reaction Reverse transcription was performed with 2 µg of total RNA. Real time PCR for PPAR-γ, C/eBP-α, FAS, CD68, F4/80, TNF-α, IL-1β, IL-6, and β-actin was performed as described previously, utilizing Takara thermal cycler, which used SYBER premix agents, as per the instructions from Takara Bio Inc. PPAR-γ for, 5′-CCA GAG CAT GGT GCC TTC GCT-3′, rev, 5′-CAG CAA CCA TTG GGT CAG CTC-3′; C/EBP-α for, 5′-GAA CAG CAA CGA GTA CCG GGT A-3′, rev, 5′-GCC ATG GCC TTG ACC AAG GAG-3′; FAS for, 5′-TGA TGT GGA ACA CAG CAA GG-3′, rev, 5′-GGC TGT GGT GAC TCT TAG TGA TAA-3′; aFABP for, 5′-TGA TGC CTT TGT GGG AAC CT-3′, rev, 5′-GCA AAG CCC ACT CCC ACT T-3′; CD68 for, 5′-TTC AGG GTG GAA GAA AGG TAA AGC-3′, rev, 5′-CAA TGA TGA GAG GCA GCA AGA GG-3′; F4/80 for, 5′-TCC AGC ACA TCC AGC CAA AGC-3′, rev, 5′-CCT CCA CTA GCA TCC AGA AGA AGC-3′; TNF-α for, 5′-TCT TCT CAT TCC TGC TTG TGG-3′, rev, 5′-GGT CTG GGG CAT AGA ACT GA-3′; IL-1β for, 5′-AAC CTG CTG GTG TGT GAC GTT C-3′, rev, 5′-CAG CAC GAG GCT TTT TTG TTG T-3′; IL-6 for, 5′-CCG CTA TGA AGT TCC TCT CTG C-3′, rev, 5′-ATC CTC TGT GAA GTC TCC TCT CC-3′; β-actin for, 5′-CCG TGA AAA GAT GAC CCA GAT C-3′, rev, 5′-CAC AGC CTG GAT GGC TAC GT-3′; Pref-1 for, 5′-GAG ACC TTG ACC GAG TCT GC-3′, rev, 5′-TTT GGA TGG AGG AGG AGT TG-3′; C/EBP-δ for, 5′-ATC GCT GCA GCT TCC TAT GT-3′, rev, 5′-AGT CAT GCT TTC CCG TGT TC-3′, Glucocorticoid receptor (GR) for, 5′-AGG CCG CTC AGT GTT TTC TA-3′, rev, 5′-TAC AGC TTC CAC ACG TCA GC-3′. Thermal cycling conditions were as follows: activation of DNA polymerase at 95°C for 10 min, followed by 40 cycles of amplification at 95°C for 30 s and at 60°C for 30 s. The normalized expression of the target gene, with respect to β-actin, was computed for all samples by using the Microsoft Excel data spreadsheet.
Analsysis of Blood Triglyceride, Total Cholesterol and HDL-Cholesterol Blood concentrations of glucose, triglyceride, Total cholesterol, and HDL-cholestrol were determined, using enzymatic kits (Asan Pharm, Hwaseong, Korea). The plasma insulin concentrations were determined, via the use of ultrasensitive eLISA kit (ALPCO, Salem, NH, U.S.A.).
Statistical Analysis The data were expressed as the mean± standard error. Statistical analysis was performed using Student's t-test for comparison between the two groups. One way analysis of variance (ANOVA) was used for comparisons between multiple groups.
ReSULTS AND DISCUSSION
First, we examined the effect of ginsenoside Rh1 on adipogenesis in 3T3-L1 cells (Fig. 1A) . Ginsenoside Rh1 potently inhibited the adipogenesis, as assessed by Oil-red O staining and lipid contents in 3T3-L1 adipocytes. Ginsenoside Rh1, at concentrations of 50 µM and 100 µM, inhibited the adipogenesis by 50% and 63%, respectively (Fig. 1B) .
Next, we examined the expression levels of adipocytespecific genes such as PPAR-γ, C/eBP-α, FAS, aFABP and some genes during early phase of differentiation such as Pref-1, C/eBP-δ and GR. After the treatment with ginsenoside Rh1 in 3T3-L1 cells, mRNA was extracted on 18 h and 24 h for Pref-1, C/eBP-δ and GR and day 8 for PPAR-γ, C/eBP-α, FAS, aFABP. Then, the expression profiles of adipocyte-specific genes were investigated by RT-PCR (Fig. 1C) . PPAR-γ, C/eBP-α, FAS, and aFABP expressions were significantly increased in DMI-stimulated differentiated adipocyte compared to those of non-stimulated adipocyte cells. However, treatment with DMI in the presence of ginsenoside Rh1 significantly suppressed the expression levels of PPAR-γ, C/eBP-α, FAS, and aFABP in a dose-dependent manner, whereas the expression levels of Pref-1, C/eBP-δ and GR were not affected (data not shown). Ginsenoside Rh1 at tested concentrations (within 150 µM) did not affect viability of 3T3-L1 cells by crystal violet staining.
When HFD fed mice for 8 weeks, body and epididymal fat weight gains were significantly increased compared to those of LFD-fed mice (Table 1) . However, when ginsenoside Rh1 was treated in HFD-fed mice, body and epididymal fat weight gains were significantly decreased compared with those of the HFD-fed mice (Table 1) . TG, glucose, insulin, total cholesterol, and HDL levels in the blood were significantly increased in HFD-fed mice group compared to LFD-fed mice group (Table  1) . However. treatment with ginsenoside Rh1 in HFD-fed mice significantly lowered TG level alone (Table 1) .
We also investigated epididymal fat pad by histological analysis. The number of bigger epididymal cells was significantly increased in the HFD group as compared to the LFD group. However, treatment with HFD in the presence of ginsenoside Rh1 reduced number of bigger epididymal cells, as well as their sizes (Fig. 2B) . Next, we extracted mRNA in epididymal fat tissue, and measured adipogenesis markers by real time-PCR. HFD increased PPAR-γ and C/eBP-α, the main transcriptional factors that are involved in the differentiation of preadipocyte.
11) However, treatment with ginsenoside Rh1 reduced the expression levels of these markers (Figs. 3A, B). Ginsenoside Rh1 also inhibited PPAR-γ, C/eBP-α, FAS, aFABP protein expression, even when they were measured by immunoblotting (Fig. 2C ). FAS and aFABP, which are involved in the synthesis of fatty acids, 11) and CD68 and F4/80, a transmembrane protein present on the cell-surface of macrophages, were measured (Figs. 3C-F) . HFD increased these expression levels. However, treatment with ginsenoside Rh1 significantly down-regulated these expression levels. Furthermore, the expression levels of pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1β were measured. HFD increased these gene expression levels by 50%, 62%, and 76%, respectively. However, ginsenoside Rh1 group suppressed these gene expression levels (Figs. 3G-I ). Ginsenoside Rh1 also inhibited TNF-α, IL-6, and IL-1β in blood, even when they measured by eLISA (Figs. 2D-F) . However, mice treated with ginsenoside Rh1 did not show the toxicity.
Many studies reports that obesity may be related to inflammation. 1, 12) Recently, natural active compounds, such as ginsenosides, are highlighted as materials that control obesity. 12, 13) For example, Hwang et al. suggested that ginsenoside Rh2, a representative protopanaxadiol, may suppress adipogenesis by inhibiting PPARγ expression. 7) Niu et al. reported that ginsenoside Rh2 can induce differentiation of preadipocyte. 8) Nevertheless, its in vivo studies have not been studied. Therefore, to understand the possible role of protopanaxatriol ginsensoides, we measured the inhibitory effects of protopaxdiol ginsenosides Re, Rg1 and Rh1 against adipocyte differentiation (data not shown). Of them, ginsenoside Rh1 inhibited adipocyte differentiation most potently. Furthermore, ginsenosides Re and Rg1 were metabolized to ginsenoside Rh1 by human intestinal microflora.
9) Ginsenoside Rh1 suppressed the adipogensis and inflammation markers and the body and epididymal fat weight gains in HFD-treated mice. Ginsenoside Rh1 inhibited the expression of TNF-α, IL-6 and IL-1β, as well as macrophage antigen, CD68 and F4/80. Thus, ginsenoside Rh1 inhibited the infiltration of macrophage into the epididymal tissue of HFDtreated mice. Although the detailed inhibitory mechanism of ginsenoside Rh1 in 3T3-L1 cell adipocyte differentiation was not fully elucidated, ginsenoside Rh1 potently inhibited the dominant adipogenic markers. Based on these findings, ginsenoside Rh1 may inhibit obesity by inhibiting adipocyte differentiation and inflammation.
